Biopharmaceutical Excipients Market Provides An In-Depth Insight Of Sales And Trends Forecast To 2027
The global biopharmaceutical excipients market size is projected to reach USD 3.0 billion by 2027, exhibiting a CAGR of 5.9%, according to a new report by Radiant Insights, Inc. The demand for biopharmaceutical excipients is anticipated to increase given that several biologicals will be expiring over the next few years. Rapidly evolving development and manufacturing of biosimilars are further contributing to the increasing demand for novel biopharmaceutical excipients. Continuous advancements in the pharmaceutical industry, reduced time taken for manufacturing products, and outsourcing also significantly drive the product demand.
The concept of multifunctional or smart excipients has piqued the interest of market participants owing to their enhanced compressibility and drug release ability. Moreover, they have the ability to overcome challenges associated with drug formulation such as complex drug manufacturing processes and high costs associated with incorporating these products in drugs. Maintaining drug stability while reducing overall costs associated with drug development is of utmost importance to achieve large-scale commercial biopharmaceutical manufacturing.
Download Free Sample Report @ https://www.radiantinsights.com/research/biopharmaceutical-excipients-market/request-sample
Thus, market players are investing in the development of multifunctional excipient products to sustain intensifying competition in the industry. Various commercial multifunctional/smart excipients include Ludipress (BASF SE), F-MELT (Fuji Chemical Industries Co., Ltd.), Galen IQ 721 (BENEO-Palatinit GmbH), and MCC SANAQ (Pharmatrans-Sanaq AG).
Further key findings from the report suggest:
• Increasing focus of pharmaceutical players on utilizing recombinant protein and monoclonal antibodies for bio-generic drug development is expected to drive the biopharmaceutical excipients market growth in the coming years
• Solubilizers and surfactants/emulsifiers accounted for a significant share in 2019 as they help maintain adequate efficacy of preservatives or antimicrobials in drug formulations
• Polyols are anticipated to exhibit the fastest growth in terms of revenue from 2020 to 2027, as they are gaining significant traction across the latest drug formulations such as chewable tablets and lozenges
• North America dominated the overall market in terms of revenue whereas Asia Pacific dominated the market in terms of volume in 2019
• Key industry participants include Roquette Frères, Spectrum Chemical Manufacturing Corp., Merck KGaA, Colorcon, and BASF SE
• Companies are inclined toward strategic agreements to maintain their market position. For instance, in February 2019, ABITEC (SPI Pharma) entered into a distribution agreement with Indchem International to distribute ABITEC’s functional lipid excipient product line into the personal care, nutrition, and cosmeceutical markets in India
Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/biopharmaceutical-excipients-market
Table of Contents
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Methodology and Scope
2.1 Market Segmentation & Scope
2.1.1 Estimates and Forecast Timeline
2.2 Research Methodology
2.3 Information Procurement
2.3.1 Purchased database:
2.3.2 Radiant Insights internal database
2.3.3 Secondary sources:
2.3.4 Primary Research:
2.3.5 Details of Primary Research
2.3.5.1 Data for primary interviews in North America
2.3.5.2 Data for primary interviews in Europe
2.3.5.3 Data for primary interviews in Asia Pacific
2.3.5.4 Data for primary interviews in Latin America
2.3.5.5 Data for primary interviews in MEA
2.4 Information or Data Analysis
2.4.1 Data Analysis Models
2.5 Market Formulation & Validation
2.6 Model Details
2.6.1 Commodity Flow Analysis (Model 1)
2.6.1.1 Approach 1: Commodity Flow Approach
2.6.2 Volume Price Analysis (Model 2)
2.6.2.1 Approach 2: Volume Price Analysis
2.7 List of Secondary Sources
2.8 List of Primary Sources
2.9 Objectives
2.9.1 Objective 1
2.9.2 Objective 2
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Chemical and physical instability of biopharmaceuticals is boosting the development of excipients
3.1.1.2 Increase in focus of pharmaceutical players on bio generic market
3.1.1.3 Cost-efficiency and competency of manufacturers
3.1.1.4 Patent expiry of biological actives
3.1.1.5 Rising adoption of multifunctional excipients
3.1.2 Market restraint analysis
3.1.2.1 Challenges in development of excipients for biologics
3.1.2.2 Issues pertaining to supply chain in biopharmaceutical industry
Continued…
Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceutical
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: [email protected]
Website: https://www.radiantinsights.com/